138 related articles for article (PubMed ID: 9545222)
1. Autoinducer of virulence as a target for vaccine and therapy against Staphylococcus aureus.
Balaban N; Goldkorn T; Nhan RT; Dang LB; Scott S; Ridgley RM; Rasooly A; Wright SC; Larrick JW; Rasooly R; Carlson JR
Science; 1998 Apr; 280(5362):438-40. PubMed ID: 9545222
[TBL] [Abstract][Full Text] [Related]
2. A possible new approach to combating Staph infections.
Strauss E
Science; 1998 Apr; 280(5362):379. PubMed ID: 9575082
[No Abstract] [Full Text] [Related]
3. Regulation of Staphylococcus aureus pathogenesis via target of RNAIII-activating Protein (TRAP).
Balaban N; Goldkorn T; Gov Y; Hirshberg M; Koyfman N; Matthews HR; Nhan RT; Singh B; Uziel O
J Biol Chem; 2001 Jan; 276(4):2658-67. PubMed ID: 11160124
[TBL] [Abstract][Full Text] [Related]
4. Regulation of agr-dependent virulence genes in Staphylococcus aureus by RNAIII from coagulase-negative staphylococci.
Tegmark K; Morfeldt E; Arvidson S
J Bacteriol; 1998 Jun; 180(12):3181-6. PubMed ID: 9620969
[TBL] [Abstract][Full Text] [Related]
5. Characterization of RAP, a quorum sensing activator of Staphylococcus aureus.
Korem M; Sheoran AS; Gov Y; Tzipori S; Borovok I; Balaban N
FEMS Microbiol Lett; 2003 Jun; 223(2):167-75. PubMed ID: 12829282
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Staphylococcus aureus pathogenesis in vitro and in vivo by RAP-binding peptides.
Yang G; Cheng H; Liu C; Xue Y; Gao Y; Liu N; Gao B; Wang D; Li S; Shen B; Shao N
Peptides; 2003 Nov; 24(11):1823-8. PubMed ID: 15019215
[TBL] [Abstract][Full Text] [Related]
7. Detection of the response regulator AgrA in the cytosolic fraction of Staphylococcus aureus by monoclonal antibodies.
Morfeldt E; Panova-Sapundjieva I; Gustafsson B; Arvidson S
FEMS Microbiol Lett; 1996 Oct; 143(2-3):195-201. PubMed ID: 8837472
[TBL] [Abstract][Full Text] [Related]
8. RNAIII inhibiting peptide (RIP), a global inhibitor of Staphylococcus aureus pathogenesis: structure and function analysis.
Gov Y; Bitler A; Dell'Acqua G; Torres JV; Balaban N
Peptides; 2001 Oct; 22(10):1609-20. PubMed ID: 11587789
[TBL] [Abstract][Full Text] [Related]
9. Autocrine regulation of toxin synthesis by Staphylococcus aureus.
Balaban N; Novick RP
Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1619-23. PubMed ID: 7533297
[TBL] [Abstract][Full Text] [Related]
10. Vaccination with VLPs Presenting a Linear Neutralizing Domain of
Joyner JA; Daly SM; Peabody J; Triplett KD; Pokhrel S; Elmore BO; Adebanjo D; Peabody DS; Chackerian B; Hall PR
Toxins (Basel); 2020 Jul; 12(7):. PubMed ID: 32664481
[TBL] [Abstract][Full Text] [Related]
11. RNAIII activates map expression by forming an RNA-RNA complex in Staphylococcus aureus.
Liu Y; Mu C; Ying X; Li W; Wu N; Dong J; Gao Y; Shao N; Fan M; Yang G
FEBS Lett; 2011 Mar; 585(6):899-905. PubMed ID: 21349272
[TBL] [Abstract][Full Text] [Related]
12. A novel peptide screened by phage display can mimic TRAP antigen epitope against Staphylococcus aureus infections.
Yang G; Gao Y; Dong J; Liu C; Xue Y; Fan M; Shen B; Shao N
J Biol Chem; 2005 Jul; 280(29):27431-5. PubMed ID: 15908434
[TBL] [Abstract][Full Text] [Related]
13. Activation of alpha-toxin translation in Staphylococcus aureus by the trans-encoded antisense RNA, RNAIII.
Morfeldt E; Taylor D; von Gabain A; Arvidson S
EMBO J; 1995 Sep; 14(18):4569-77. PubMed ID: 7556100
[TBL] [Abstract][Full Text] [Related]
14. RNAIII inhibiting peptide (RIP) inhibits agr-regulated toxin production.
Vieira-da-Motta O; Ribeiro PD; Dias da Silva W; Medina-Acosta E
Peptides; 2001 Oct; 22(10):1621-7. PubMed ID: 11587790
[TBL] [Abstract][Full Text] [Related]
15. Translation of RNAIII, the Staphylococcus aureus agr regulatory RNA molecule, can be activated by a 3'-end deletion.
Balaban N; Novick RP
FEMS Microbiol Lett; 1995 Nov; 133(1-2):155-61. PubMed ID: 8566701
[TBL] [Abstract][Full Text] [Related]
16. Treatment efficacy of the lead RNAIII-inhibiting peptide YSPWTNF-NH2 in acquired Staphylococcus aureus sepsis: a histopathological assessment.
Ribeiro PD; Ribeiro OD; Marcolan AM; Medina-Acosta E
Peptides; 2003 Nov; 24(11):1829-36. PubMed ID: 15019216
[TBL] [Abstract][Full Text] [Related]
17. Variation in the agr-dependent expression of alpha-toxin and protein A among clinical isolates of Staphylococcus aureus from patients with septicaemia.
Li S; Arvidson S; Möllby R
FEMS Microbiol Lett; 1997 Jul; 152(1):155-61. PubMed ID: 9228782
[TBL] [Abstract][Full Text] [Related]
18. RIP-V improves murine survival in a sepsis model by down-regulating RNAIII expression and α-hemolysin release of methicillin-resistant Staphylococcus aureus.
Ma B; Zhou Y; Li M; Yu Q; Xue X; Li Z; Da F; Hou Z; Luo X
Pharmazie; 2015 Feb; 70(2):81-7. PubMed ID: 25997246
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel two-component regulatory system that acts in global regulation of virulence factors of Staphylococcus aureus.
Yarwood JM; McCormick JK; Schlievert PM
J Bacteriol; 2001 Feb; 183(4):1113-23. PubMed ID: 11157922
[TBL] [Abstract][Full Text] [Related]
20. RNAIII Inhibiting Peptide (RIP) and Derivatives as Potential Tools for the Treatment of S. aureus Biofilm Infections.
Ciulla M; Di Stefano A; Marinelli L; Cacciatore I; Di Biase G
Curr Top Med Chem; 2018; 18(24):2068-2079. PubMed ID: 30345922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
